Kingdon Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Hold |
0
| – | – | – | 132 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 118 |
|
|
2017
Q2 | – | Sell |
-288,392
| Closed | -$4.04M | – | 121 |
|
|
2017
Q1 | $4.04M | Sell |
288,392
-130,340
| -31% | -$1.82M | 0.22% | 68 |
|
|
2016
Q4 | $6.68M | Buy |
418,732
+16,276
| +4% | +$260K | 0.32% | 61 |
|
|
2016
Q3 | $6.7M | Sell |
402,456
-242,112
| -38% | -$4.03M | 0.31% | 58 |
|
|
2016
Q2 | $7.21M | Buy |
644,568
+180,000
| +39% | +$2.01M | 0.4% | 49 |
|
|
2016
Q1 | $3.88M | Sell |
464,568
-470,000
| -50% | -$3.93M | 0.21% | 68 |
|
|
2015
Q4 | $8.7M | Sell |
934,568
-1,008,699
| -52% | -$9.39M | 0.42% | 43 |
|
|
2015
Q3 | $21.9M | Sell |
1,943,267
-198,568
| -9% | -$2.24M | 1.06% | 19 |
|
|
2015
Q2 | $27.2M | Buy |
2,141,835
+209,646
| +11% | +$2.66M | 1.06% | 16 |
|
|
2015
Q1 | $18M | Sell |
1,932,189
-529,116
| -21% | -$4.92M | 0.76% | 32 |
|
|
2014
Q4 | $35.2M | Buy |
2,461,305
+656,125
| +36% | +$9.4M | 1.53% | 12 |
|
|
2014
Q3 | $18.7M | Buy |
1,805,180
+64,780
| +4% | +$672K | 0.84% | 24 |
|
|
2014
Q2 | $28.2M | Buy |
1,740,400
+586,458
| +51% | +$9.49M | 1.08% | 10 |
|
|
2014
Q1 | $18.7M | Buy |
1,153,942
+114,592
| +11% | +$1.86M | 0.96% | 21 |
|
|
2013
Q4 | $12.9M | Buy |
1,039,350
+190,700
| +22% | +$2.36M | 0.59% | 36 |
|
|
2013
Q3 | $9.3M | Buy |
848,650
+402,800
| +90% | +$4.41M | 0.46% | 49 |
|
|
2013
Q2 | $3.59M | Buy |
+445,850
| New | +$3.59M | 0.21% | 99 |
|